TGA Approval

PRALUENT alirocumab (rch) 75mg/mL solution for injection, pre-filled pen (238285)

ARTG ID

238285

ARTG Name

PRALUENT alirocumab (rch) 75mg/mL solution for injection, pre-filled pen

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

May 17, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-01965-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01366-1

Ingredient Name

alirocumab

Empowering clinical research with data-driven insights and AI-powered tools.

PRALUENT alirocumab (rch) 75mg/mL solution for injection, pre-filled pen (238285) - TGA 批准文号 | MedPath